Ratiopharm set to launch first biosimilar G-CSF in the EU
This article was originally published in Scrip
Executive Summary
Ratiopharmis set to launch its biosimilar G-CSF filgrastim product, Ratiograstim, in the UK and Germany next month, and in France, Italy and Spain in 2009.